Dingfeng Li, MD
Primary Location
Cleveland Clinic Main Campus
- Appointment:
- 216.445.7568
- Desk:
- 216.445.7568
- Fax:
- 216.445.1656
Treatment & Services
- Cardiovascular Disease Risk Prevention
- Male Infertility Testing
Specialty in Diseases & Conditions
- Acanthosis Nigricans
- Acne
- Acromegaly
- Addison's Disease
- Adrenal Disorders
- Adrenal Insufficiency
- Adrenal Tumors
- Adrenocortical Carcinoma
- Adrenoleukodystrophy (ALD)
- Alopecia Areata
- Amenorrhea
- Androgen Deficiency (Low Testosterone)
- Androgen Excess
- Beta-Cell Disorders
- Bone Disorders
- Carcinoid Syndrome
- Conn's Syndrome
- Cushing's Syndrome
- Diabetes
- Diabetes, Gestational
- Diabetic Retinopathy
- Dysmenorrhea
- Empty Sella
- Erectile Dysfunction
- Familial Multiple Endocrine Neoplasia
- Fasting Hypoglycemia
- Flushing Syndromes
- Galactorrhea
- Goiter
- Growth Hormone Deficiency
- Growth Hormone Excess
- Gynecomastia
- Hair Loss
- High Cholesterol
- Hirsutism
- Hyperaldosteronism
- Hyperandrogenism
- Hypercalcemia
- Hyperprolactinemia
- Hypertension - High Blood Pressure
- Hyperthyroidism
- Hypertriglyceridemia
- Hypocalcemia
- Hypogonadism
- Hypoparathyroidism
- Hypophysitis
- Hypopituitarism
- Hypothyroidism
- Infertility
- Klinefelter Syndrome
- Mastocytosis
- Menopause
- Menopause, Male
- Metabolic Diseases
- Metabolic Syndrome
- Neuropathy - Diabetic
- Obesity
- Osteopenia
- Osteoporosis
- Ovarian Cysts
- Pancreatic Cancer
- Panhypopituitarism
- Parathyroid Cancer
- Parathyroid Disease
- Periodic Paralysis
- Pheochromocytoma
- Pituitary Cysts
- Pituitary Stalk Lesions
- Pituitary Tumors
- Polycystic Ovary Syndrome
- Premenstrual Syndrome (PMS)
- Primary Hyperaldosteronism
- Prolactin Excess States
- Prolactinoma
- Pseudohypoparathyroidism
- Reactive Hypoglycemia
- Secondary Hyperparathyroidism
- Sexual Dysfunction
- Sexual Hormone Disorders
- Tertiary Hyperparathyroidism
- Thyroid and Pregnancy
- Thyroid Cancer
- Thyroid Disease
- Thyroid Nodule
- Zollinger-Ellison Syndrome
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Dingfeng Li, MD
Dr. Li is a staff physician at the Endocrinology and Metabolism Institute of the Cleveland Clinic Main Campus. After graduating with honors from Shanghai Jiao Tong University School of Medicine in 2014, he completed internal medicine residency at the John Stroger Hospital of Cook County in Chicago and was certified by the American Board of Internal Medicine in 2018. Concurrent to residency training, he obtained a Master of Science degree in Clinical Research at the Rush University. He then completed a three-year clinical and research fellowship in Endocrinology, Diabetes and Metabolism at the Mayo Clinic in Rochester, Minnesota, where he had an academic rank of Assistant Professor in Medicine. He joined the Cleveland Clinic after graduating from the fellowship in 2021. He currently holds an academic rank of Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine, Case Western Reserve University.
Dr. Li has a strong clinical and research interest in pituitary and adrenal disorders. He has published multiple peer-reviewed manuscripts of original research and review in major endocrinology journals. He is an active member with several medical professional societies. He has been recognized by academic societies with various scholarship and travel awards.
Education & Professional Highlights
Appointed
2021
Education & Fellowships
Fellowship - Mayo Clinic Rochester, MN
Endocrinology, Diabetes and Metabolism
Rochester,
MN USA
2021
Residency - John H. Stroger Jr. Hospital of Cook County
Internal Medicine
Chicago,
IL USA
2018
Graduate School - RUSH UNIVERSITY
Clinical Research
CHICAGO,
IL USA
2018
Internship - John H. Stroger Jr. Hospital of Cook County
Internal Medicine
Chicago,
IL USA
2016
Medical Education - Shanghai Jiao Tong University School of Medicine
Clinical Medicine
Shanghai,
China
2014
Certifications
- Internal Medicine
- Internal Medicine - Endocrinology, Diabetes and Metabolism
Specialty Interests
Pituitary and adrenal disorders
Awards & Honors
- Outstanding Abstract Award - ENDO 2021, Endocrine Society 2021
- Early Career Forum Travel Award - ENDO 2020, Endocrine Society 2020
- Fellow’s Travel Award - ADA 79th Annual Scientific Sessions, American Diabetes Association 2019
- Outstanding Graduate Award - Shanghai Jiao Tong University 2014
- Merck-Serono China Elite Awards - Merck & Co. Inc. 2012
- Top Grade Scholarship - Shanghai Jiao Tong University 2007, 2008, 2009
- National Scholarship of China - Ministry of Education of the People's Republic of China 2007
Research & Publications
See publications for Dingfeng Li, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/18/2022, Dr. Li has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.